All Relations between Alzheimer Disease and prosencephalon

Reference Sentence Publish Date Extraction Date Species
Sara Rose Dunlop, Ivan Ayala, Callen Spencer, Margaret E Flanagan, Marek-Marsel Mesulam, Tamar Gefen, Changiz Geul. Resistance of Basal Forebrain Cholinergic Neurons to TDP-43 Proteinopathy in Primary Progressive Aphasia. Journal of neuropathology and experimental neurology vol issue 2022 36111818 basal forebrain cholinergic neurons (bfcn) display accumulation of neurofibrillary tangles and degeneration in alzheimer disease and are targets of therapeutic intervention. 2022-09-16 2022-09-20 Not clear
Chiara Orciani, Helene Hall, Rowan Pentz, Morgan K Foret, Sonia Do Carmo, A Claudio Cuell. Long-term nucleus basalis cholinergic depletion induces attentional deficits and impacts cortical neurons and BDNF levels without affecting the NGF synthesis. Journal of neurochemistry vol issue 2022 35921478 basal forebrain cholinergic neurons (bfcns) represent the main source of cholinergic innervation to the cortex and hippocampus and degenerate early in alzheimer's disease (ad) progression. 2022-08-03 2022-08-08 Not clear
Xiaoqing Alice Zhou, Grace Ngiam, Lei Qian, Kornraviya Sankorrakul, Elizabeth J Coulson, Kai-Hsiang Chuan. The basal forebrain volume reduction detected by MRI does not necessarily link with the cholinergic neuronal loss in the Alzheimer's disease mouse model. Neurobiology of aging vol 117 issue 2022 35640461 the basal forebrain volume reduction detected by mri does not necessarily link with the cholinergic neuronal loss in the alzheimer's disease mouse model. 2022-05-31 2022-06-13 Not clear
Xiaoqing Alice Zhou, Grace Ngiam, Lei Qian, Kornraviya Sankorrakul, Elizabeth J Coulson, Kai-Hsiang Chuan. The basal forebrain volume reduction detected by MRI does not necessarily link with the cholinergic neuronal loss in the Alzheimer's disease mouse model. Neurobiology of aging vol 117 issue 2022 35640461 degeneration of cholinergic neurons in the basal forebrain (bf) contributes to cognitive impairment in alzheimer's disease (ad) and other disorders. 2022-05-31 2022-06-13 Not clear
Helga Eyjolfsdottir, Thomas Koenig, Azadeh Karami, Per Almqvist, G\\xc3\\xb6ran Lind, Bengt Linderoth, Lars Wahlberg, \\xc3\\x85ke Seiger, Taher Darreh-Shori, Maria Eriksdotter, Vesna Jeli. Fast Alpha Activity in EEG of Patients With Alzheimer's Disease Is Paralleled by Changes in Cognition and Cholinergic Markers During Encapsulated Cell Biodelivery of Nerve Growth Factor. Frontiers in aging neuroscience vol 14 issue 2022 35557841 basal forebrain cholinergic neurons are dependent on nerve growth factor (ngf) for growth and survival and these cells are among the first to degenerate in alzheimer's disease (ad). 2022-05-13 2022-06-13 Not clear
Weilin Liu, Jianhong Li, Minguang Yang, Xiaohua Ke, Yaling Dai, Huawei Lin, Sinuo Wang, Lidian Chen, Jing Ta. Chemical genetic activation of the cholinergic basal forebrain hippocampal circuit rescues memory loss in Alzheimer's disease. Alzheimer's research & therapy vol 14 issue 1 2022 35418161 chemical genetic activation of the cholinergic basal forebrain hippocampal circuit rescues memory loss in alzheimer's disease. 2022-04-14 2022-04-15 Not clear
Weilin Liu, Jianhong Li, Minguang Yang, Xiaohua Ke, Yaling Dai, Huawei Lin, Sinuo Wang, Lidian Chen, Jing Ta. Chemical genetic activation of the cholinergic basal forebrain hippocampal circuit rescues memory loss in Alzheimer's disease. Alzheimer's research & therapy vol 14 issue 1 2022 35418161 the degeneration of the cholinergic circuit from the basal forebrain to the hippocampus contributes to memory loss in patients suffering from alzheimer's disease (ad). 2022-04-14 2022-04-15 Not clear
Naveen Kumar, Vijay Kumar, Piyush Anand, Vinay Kumar, Ashish Ranjan Dwivedi, Vinod Kuma. Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease. Bioorganic & medicinal chemistry vol 61 issue 2022 35398739 alzheimer's disease (ad) is a multifactorial irreversible neurological disorder which results in cognitive impairment, loss of cholinergic neurons in synapses of the basal forebrain and neuronal death. 2022-04-10 2022-04-14 Not clear
Ezio Giacobini, A Claudio Cuello, Abraham Fishe. Reimagining cholinergic therapy for Alzheimer's disease. Brain : a journal of neurology vol issue 2022 35289363 the review provides an updated view of the basal forebrain cholinergic system, its relation to cognition, and its relevance for therapy of alzheimer's disease. 2022-03-15 2022-04-14 Not clear
Ezio Giacobini, A Claudio Cuello, Abraham Fishe. Reimagining cholinergic therapy for Alzheimer's disease. Brain : a journal of neurology vol issue 2022 35289363 it also addresses the discovery of a novel nerve growth factor metabolic pathway responsible for the trophic maintenance of the basal forebrain system and its deregulation in alzheimer's disease. 2022-03-15 2022-04-14 Not clear
Chen-Pei Lin, Irene Frigerio, Baayla D C Boon, Zihan Zhou, Annemieke J M Rozemuller, Femke H Bouwman, Menno M Schoonheim, Wilma D J van de Berg, Laura E Jonkma. Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease. Brain : a journal of neurology vol issue 2022 35259207 cognitive deficits in alzheimer's disease, specifically amnestic (memory dominant) deficits, are associated with cholinergic degeneration in the basal forebrain. 2022-03-08 2022-04-14 Not clear
Stefan J Teipel, Michel J Groth. Ante-mortem basal forebrain atrophy in pure limbic TAR DNA-binding protein 43 pathology compared with pure Alzheimer pathology. European journal of neurology vol issue 2022 35122358 ante-mortem basal forebrain atrophy in pure limbic tar dna-binding protein 43 pathology compared with pure alzheimer pathology. 2022-02-05 2022-02-06 Not clear
Stefan J Teipel, Michel J Groth. Ante-mortem basal forebrain atrophy in pure limbic TAR DNA-binding protein 43 pathology compared with pure Alzheimer pathology. European journal of neurology vol issue 2022 35122358 currently, the extent of cholinergic basal forebrain atrophy in relatively pure limbic tar dna-binding protein 43 (tdp-43) pathology compared with relatively pure alzheimer's disease (ad) is unclear. 2022-02-05 2022-02-06 Not clear
Selena Gonzalez, Tyne L M McHugh, Tao Yang, Wassim Syriani, Stephen M Massa, Frank M Longo, Danielle A Simmon. Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer's disease mouse model at an advanced pathological stage. Neurobiology of disease vol 162 issue 2021 34838668 degeneration of basal forebrain cholinergic neurons (bfcns) in the nucleus basalis of meynert (nbm) and vertical diagonal band (vdb) along with their connections is a key pathological event leading to memory impairment in alzheimer's disease (ad). 2022-02-04 2022-01-13 Not clear
Sonia Do Carmo, Benjamin Kannel, A Claudio Cuell. The Nerve Growth Factor Metabolic Pathway Dysregulation as Cause of Alzheimer's Cholinergic Atrophy. Cells vol 11 issue 1 2022 35011577 the cause of the loss of basal forebrain cholinergic neurons (bfcns) and their terminal synapses in the cerebral cortex and hippocampus in alzheimer's disease (ad) has provoked a decades-long controversy. 2022-02-04 2022-01-13 Not clear
Melissa J Alldred, Sai C Penikalapati, Sang Han Lee, Adriana Heguy, Panos Roussos, Stephen D Ginsber. Profiling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer's Disease. Molecular neurobiology vol 58 issue 10 2021 34263425 profiling basal forebrain cholinergic neurons reveals a molecular basis for vulnerability within the ts65dn model of down syndrome and alzheimer's disease. 2022-02-03 2022-01-13 Not clear
Melissa J Alldred, Sai C Penikalapati, Sang Han Lee, Adriana Heguy, Panos Roussos, Stephen D Ginsber. Profiling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer's Disease. Molecular neurobiology vol 58 issue 10 2021 34263425 basal forebrain cholinergic neuron (bfcn) degeneration is a hallmark of down syndrome (ds) and alzheimer's disease (ad). 2022-02-03 2022-01-13 Not clear
Margaret Fahnestock, Arman Shekari, Chengbiao W. Mechanisms of neurodegeneration: How oxidative stress reduces proNGF axonal transport in basal forebrain cholinergic neurons. Alzheimer's & dementia : the journal of the Alzheimer's Association vol 17 Suppl 3 issue 2022 35109078 profound and early basal forebrain cholinergic neuron (bfcn) degeneration is a hallmark of alzheimer's disease. 2022-02-03 2022-02-06 Not clear
Rowan Pentz, M Florencia Iulita, Adriana Ducatenzeiler, David A Bennett, A Claudio Cuell. The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease. Molecular psychiatry vol issue 2021 32488129 basal forebrain cholinergic neurons require ngf for maintenance of cholinergic phenotype, are critical for cognition, and degenerate early in alzheimer's disease (ad). 2022-02-01 2022-01-13 Not clear
Sarra Djemil, Claire R Ressel, Mai Abdel-Ghani, Amanda K Schneeweis, Daniel T S Pa. Central Cholinergic Synapse Formation in Optimized Primary Septal-Hippocampal Co-cultures. Cellular and molecular neurobiology vol 41 issue 8 2021 32860154 septal innervation of basal forebrain cholinergic neurons to the hippocampus is critical for normal learning and memory and is severely degenerated in alzheimer's disease. 2022-02-01 2022-01-13 Not clear
Page: 
1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37